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We applied PCR strategies to detect the common types of
α- thalassemia　 determinants　 which　 were　 associated　 with β-
thalassemia in northern Thailand. Two types of deletions in
the　 α-globin　 gene　 locus;the　 18　kb　 deletion　 of　 Southeast
Asian　 type(-αSEA)and　 the　 3.7　kb　 rightward　 deletion(-α3.7),
and the most prevalent non-deletion mutation, Hb Constant
Spring(αC8,　 TAA　 to　CAA　 at　 the　 codon　 141)were　 investigated
in　22　 cases　 of　 β-thalassemia.　 Nine　 β-thalassemia　 patients
were found to be associated with one or two of these defective
α-globin　 gene　 determinants　 and　 the　 mean　 hemoglobin
concentration in these patients was 6.3 ± 1.1 g/dl whereas it
was　 5.6±.0.8　 g/dl　 in　 12　 β-thalassemia　 patients　 without　 α-
globin gene abnormalities ; the difference is statistically
insignificant (p = 0.08). The level of anemia was severe in the
β-thalassemia　 patients　 carrying　 a　 single　 α-globin　 gene
abnormality in the heterozygous compounds ; whereas the
(β-thalassemias　 withα-globin　 gene　 defects　 in　 both　 alleles
showed　 less　 severe　 anemia.　 A　 patient　 carrying　 the　 α Ｃ8
determinant in homozygous compound showed the highest
hemoglobin　 level　 among　 these β-thalassemia　 patients.
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Introduction 
 Clinical symptoms of /1 -thalassemia are primarily 
caused by the excessive accumulation of a -globin mole-
cules in erythroid cells giving rise to severe hemolysis and 
ineffective erythropoiesis in bone marrow','). The associa-
tion of defects in the a -globin biosynthesis with fl-thala-
ssemia often results in the alleviation of the clinical 
symptoms of 8 -thalassemia patients',). a -Thalassemia 
which is characterized by the decreased level of the a -
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globin synthesis is due to deletion in the a -globin gene 
locus or mutation causing the instability of a -globin 
mRNA or a -globin polypeptide chain'). Of the two a -
globin genes on the chromosome 16, the protein product of 
the a 2 gene exceeds two to three-fold over that of the a 
gene''. Therefore, mutations affecting the a 2 gene rather 
than the a 1 gene result in severe phenotypic decrease in the 
a -globin synthesis. Non-deletion mutation in the domi-
nant a 2 gene is not always compensated by the expression 
of the remaining functional a l gene and in general the 
non-deletion a + thalassemia results in more severe reduc-
tion in the a -globin synthesis than that caused by the 
deletion of the a 2 gene'). 
 In Thailand, a - and /9 -thalassemia, hemoglobin (Hb) E 
and Hb Constant Spring (CS) are prevalent'-'). 30% to 40% 
of the population are affected with at least one of the 
abnormal globin genes'). In addition, different combina-
tions of the abnormal globin genes are expressed as more 
than 60 thalassemic syndromes",). The aim of this work is 
to investigate the incidence of common a -thalassemia 
determinants in fl -thalassemia in northern Thailand''') and 
to learn whether different spectrums of molecular defects 
in a -thalassemia associated with 9 -thalassemia are 
correlated to the clinical severity of the patients.
Materials and Methods 
Patients and preparation of DNA samples 
  (9 -Thalassemia patients aged seven to seventeen-year-
old were examined at Chiang Mai University Hospital. 
Hematologic data and treatments they received are sum-
marized in Table 1. The diagnosis of a -thalassemia was 
made based on the clinical features including severe 
hemolysis, ineffective erythropoiesis, hepatosplenomegaly 
and characteristic bone deformity. The hemoglobin compo-
nent analysis by electrophoresis was also used as a pa-
rameter for diagnosis. Peripheral blood samples were
Table 1. Summary of the clinical features and molecular characterization of a - and fl -globin gene defects in 22 j3 -thalasse-
mia patients in northern Thailand.
 Patient Age 4 bp-deletion Assigned a -globin Notable Hb A2 Hb Hct Blood transfusion 
   # in Q gene* genotypes** Hb-type*** (%) (g/dl) (%) interval in months Splenectomy 
   1 13 5 16 1 
   2 14 + - a SEA/ a a A F (F Barts) 2.4 5.5 16.5 1 + 
   3 12 - a SSA/ a a A/F 3 4.5 9.5 1 +
   4 dead + 
   5 11 + - a SEA/ a °S a A/F 2.9 7 21 1 
   6 17 F 2.6 6 20 1 + 
   7 10 a°Sa/a°sa F 1.6 8 24 2 
   8 7 + E/F 32.5 7 22 3 
   9 13 + a°Sa/a a A/F 3 6 18.5 1 + 
  10 12 + 6.5 20 3 
   11 11 + aOSa/a a F 2.7 5.5 17 1
   12 7 - a SEA/ a a F 4.4 6.5 20 2
  13 16 + 5 16 1 + 
  14 10 + A/F 2.5 5.5 18 1 + 
   15 14 + acsa/a a F 2.5 7 21 1 +
  16 6 + A/F 6.9 5 16 1 + 
  17 7 A/F 2.8 5 16 1 + 
  18 14 + F 2.9 7 22 2 + 
  19 13 + A/F 5 16 1 + 
  20 13 + 4.8 14 1 + 
  21 12 + F 5 16 1 + 
   22 12 - a 11A/ a a F 4.8 7 21 1 +
* the 4bp-deletion occurs in codon 41 through 42 of the Q -globin gene. 
* *refer to the text for the description of the each a -globin gene determinant. 
* * * Abreviations : A, F and E are hemoglobin A, F and E, respectively.
collected from 22 cases of R -thalassemia and DNA was 
isolated from the huffy coat of each blood sample as 
described previously',") and stored at 4°C. 
Oligonucleotide primers 
 To detect the 4 bp-deletion in codon 41/42 of the j9 -
globin gene which is frequently found in the northern 
Thailand population"), the sense primer HB 1 (5'-
CCTTGGACCCAGAGGTTGAG-3') specific for the mutant 
allele and the anti-sense HB 2 (5'-CTGAAGTTCTCAG-
GATCCACGT-3') common for both normal and mutant 
alleles were synthesized. Using these primers, a 201 by 
DNA fragment was specifically amplified in the DNA 
samples of (9 -thalassemia patients carrying the 4 bp-
deletion (Figure 1). The primers, CS 1 and 2, for the 
selective amplification of the sequence between the intron 
2 and the 3' side of the termination codon of the a 2 -globin 
gene were already described previously'). Allele specific 
primers for detection of the Hb Constant Spring gene was 
originally described by Fucharoen et al 12). and an amplified 
190 by-DNA was recognized in the patients carrying the Hb 
CS determinant ( a') (Figure 2). To detect the 3.7 kb 
rightward deletion of the a -globin locus (- a " determi-
nant), the Z2 forward primer (5'-TCTCCCCTGTCCTTT-
CCCTA -3') which locates upstream to the a 2-globin gene 
and the Z1 reverse primer (5'-GTTCTAGCCATGTGTG-
TCCC -3') which is in the 3' side of the a i-globin gene were 
used. In a case affected with - a &7 determinant, the amplifi-
cation of a DNA fragment of approximately 1.7 kb was 
expected by PCR using these primers'). Southeast Asian
type a -thalassemia (- a SEA determinant) shows a 18 
kb-deletion affecting the most of a -type globin genes and 
two pseudo-genes"'). A set of primers, 5' SEA and 3' SEA 
reported by Bowden et al')., were used to identify the 18 kb 
deletion and the expected size of 560 by was amplified by 
PCR on the DNA samples of patients carrying the - a SEA 
determinant (Figure 3).
Figure 1. Detection of the 4bp-deletion in codon 41/42 of the 
Q -globin gene by PCR. 
Lane M : DNA size marker, 1 : Positive control, 2 : Negative 
control, 3 : Patient 2, 4 : Patient 4, 5 : Patient 11, 6 : Patient 15.
Figure 2. Identification of the a O5 determinant (TAA to 
CAA at the codon 141) using the allele specific primers. 
Lane M : DNA size marker, 1 : Negative control, 2 : Positve 
control, 3 : Patient 7, 4 : Patient 1, 5 : Patient 6. 
*Primers were adopted following the method of Fucharoen 
 S, Fucharoen G and Fukumaki Y12>.
Polymerase chain reaction 
 40,u 1 of sample solution was mixed with 34,u 1 of 
distilled water, 10,u 1 of 10x PCR buffer (100 mM Tris-HCl 
pH 8.4, 500 mM KCI, 15 mM MgC12, 1% Triton X100 and 
0.1 % gelatin), 2.5,u 1 of each primer solution (0.1 p g/,u 1), 
10,u 1 of 2 mM dNTP and 2.5 units of Tth DNA polymerase 
of Thermus thermophilus HB8 (Toyobo, Tokyo) in a 500 
,u 1 microfuge tube. 80 to 100p 1 of mineral oil was overlaid 
to cover the surface of the reaction mixture. PCR was 
carried out using Minicycler TM (MJ Research, 
Watertown, MA). 
 The PCR amplification conditions for the each set of 
primers were similar to those reported by other groups"-1'), 
however various modifications were tested to obtain the 
optimum results. A portion of the PCR product was 
electrophoresed on a gel consistingof 4% Nusieve agarose. 
The amplified DNA was detected by staining with 
Ethidium Bromide. In case of the Hb CS gene detection, a 
276 by DNA fragment amplified by using CS1 and CS2 
primers was digested with restriction enzyme Mse I or Tru 
91 (both obtained from Sigma Chemical Co., St. Louis, 
MO) and the digest was electrophoresed on an agarose 
gel1o) 
Clinical Laboratory Data 
 Hematologic data were provided by Dr. Torpong 
Sanguansermsri at the Hematology Clinic of the 
Department of Pediatrics, Chiang Mai University, Chiang 
Mai, Thailand.
Figure 3. Detection of the - a " determinant 
       (18kb-deletion) by PCR 
Lane M : DNA size marker, 1 : Negative control, 2 : Patient 2, 
3 : Patient 3, 4 : Patient 5, 5 : Patient 12, 6 : Patient 22. 
* The PCR strategy was based on the method of Bowden DK, 
 Vickers MA and Higgs DR"'.
Results and Discussion 
Molecular characterization of /9 -thalassemia 
 Molecular defects in the fl -thalassemia patients in this 
study were not fully elucidated. Nevertheless, 15 of 22 R -
thalassemia patients were shown to have the 4bp-deletion 
at codon 41/42 in the fl -globin gene by PCR using the 
primers HB1 and HB2 which were specific for the defective 
allele (Table 1). 
Molecular types of a -thalassemia co-associated with R -
thalassemia 
 Deletion in the a -globin gene locus is the most frequent 
cause of a -thalassemia in Southeast Asia. In particular, 
the 18 kb SEA type deletion (- a SEA), and the 3.7 kb 
rightward (- a a') and the 4.2 kb leftward (- a 42) deletion 
are prevalent defects"'). Hb CS comprises a significant 
cause of non-deletion a -thalassemia-"'). In the present 
analysis, - a SE" and a a determinants were recognized in 9
of the 22 /1 -thalassemia patients (Tablel). Among these 
fl -thalassemia patients, seven cases showed defects in the 
a -globin gene locus at either one of the two alleles ; a -g 
lobin genotypes were - a SE"/ a a in four and a a a / a a in 
three. Two cases of the /9 -thalassemia patients carried a -
globin gene abnormalities on both alleles : 
-as'/a' a and a `S a / a Cs a . In this study, the 3.7 kb 
deletion was not detected presumably due to the difficulty 
in the allele specific PCR amplification of the a -globin 
gene"'. 
Clinical evaluation of the fl -thalassemia patients with or 
without complication with a -thalassemia 
 The hemoglobin concentration in the peripheral blood of 
the j3 -thalassemia patients with or without complication 
of a -thalassemia was compared (Figure 4). The mean 
hemoglobin concentration in the R -thalassemia patients 
being complicated with a -thalassemia was 6.3 ± 1.1 g/dl 
(n = 9) and in the patients without a -globin abnormali-
ties, it was 5.6 ± 0.8 g/dl (n = 12). The difference is, 
however, statistically insignificant (p = 0.08). Among the 
/9 -thalassemia patients associated with a -thalassemia, 
the hemoglobin concentration was lower in the patients 
carrying the defective a -globin locus only in one chromo-
some. The mean value for hemoglobin in the fl -thalas-
semia patients affected with the - a SE"/ a a genotype was 
5.9 ± 1.1 g/dl (n = 4) and it was 6.2 ± 0.8 g/dl (n = 3) in 
the fl -thalassemias carrying the a a a / a a genotype. The 
level of hemoglobin concentration was slightly higher in a 
/9 -thalassemia having the - a SE"/ a a a genotype (7.0 g/dl ) 
and in a patient with homozygous a a a / a ' a determi-
nants (8.0 g/dl) (Figure 5). 
 In case of the SEA type deletion, two functional a -
genes on another chromosome compensate the a -globin 
synthesis so that a -globin can be produced to 90% of 
normal level. Mutations in the terminal codon of the a 2-
globin gene often result in severe reduction of the a -
globin synthesis since the a a mRNA is highly unstable 
and the compensation by the remaining functional a 1-
globin gene is not effective""). It is expected that the a 
gene causes a more decreased level of the a -globin synthe-
sis than that observed in the carriers of deleted a -globin 
genes. The severity in reduction of the a -globin synthesis 
caused by mutations in the a -globin genes in 8 -thalas-
semia patients in turn appears to alleviate the hemolysis 
and the suppression of erythropoiesis in bone marrow. This 
is supported by the report that the excessive accumulation 
of the denatured a -globin molecules causes the apoptotic 
cell death of erythroid precursor cells in bone marrow of 
R - thalassemias). The hemoglobin concentration in the /9 -
thalassemia patients in this study appear to correlate 
reciprocally to the degree of reduction in the a -globin 
synthesis expected by the nature of defects in the a - globin 
genes. It is also noteworthy that splenectomy was
performed in 9 out of 12 fl -thalassemia patients without 
a -globin gene defects meanwhile 5 out of 9 R -thalassemia 
patients complicated with a -thalassemia were treated 
with splenectomy. 
 The present study indicates that the different spectrums 
of molecular defects in the a -globin genes are correlated 
to the severity and prognostic evaluation of fl -thalas-
semia patients when they are complicated with a -thalas-
semia. Accumulation of the knowledge of the molecular 
defects on both a - and fl -thalassemia and careful fo How-
up studies of the patients will enable us to understand the 
pathogenesis of the diseases and to establish more effec-
tive therapeutic means.
Figure 4. The hemoglobin concentration of the fl -
thalassemia patients with or without complication of a -
thalassemia. 
* P = 0.08
Figure 5. The molecular types of a -thalassemia and the 
hemoglobin concentration in the Q -thalassemia patients.
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